P4.11E.17 Clinical Outcomes and Immunotherapy Retreatment in Patients with Metastatic NSCLC Who Complete at Least Two Years of Immune Checkpoint Blockade
Work
Year: 2024
Type: article
Source: Journal of Thoracic Oncology
Cites:
Cited by:
Related to: 10
FWCI:
Citation percentile (by year/subfield):
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed